Blood flow-interrupting hyperthermic chemotherapy on established autochthonous mouse sarcoma induced by 3-methylcholanthrene.
D000818:Animals; D001389:Azirines / Q000627:therapeutic use*; D002225:Carbazilquinone / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006979:Hyperthermia, Induced; D008748:Methylcholanthrene; D051379:Mice; D008937:Mitomycins / Q000494:pharmacology; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000503:physiopathology / Q000628:therapy*
D001389:Azirines; D008937:Mitomycins; D009588:Nitrogen Mustard Compounds; D002225:Carbazilquinone; D008748:Methylcholanthrene